Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 50,000 shares at $156.55 ($7.8M) on 2021-06-28, disclosed to the SEC on 2021-06-30.
Open-market sale of $7.8M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $156.55 | 25,000 | $3.9M | 50.0% |
| 2 | $156.55 | 25,000 | $3.9M | 50.0% |
| Total | $156.55 avg | 50,000 | $7.8M | 100% |
| Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-10-13 | $2.5M | — | Filing → |
| CRSP | SELL | 2020-09-03 | $4.6M | — | Filing → |